Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.
Press releases published on March 24, 2025
Opthea Announces COAST Phase 3 Trial Topline Results
GlobeNewswire
·
March 24, 2025
COAST Phase 3 trial failed to meet primary endpoint of mean change in BCVA from baseline to week 52 Opthea considering impact of negative trial results under its Development Funding Agreement and on the Company as a going concern MELBOURNE, Australia and …
Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma
GlobeNewswire
·
March 24, 2025
SHANGHAI, March 23, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …
Memphasys Limited (MEM.AX) Pivotal Clinical Trial Confirms Best-in-Class Performance
ABN Newswire
·
March 24, 2025
Defining Milestone for Memphasys, Felix(TM) Pivotal Clinical Trial Confirms Best-in-Class Performance - Paving the Way for Global Commercial Expansion Sydney, Mar 24, 2025 AEST (ABN Newswire) - Memphasys Limited (ASX:MEM) (IG7:FRA) is pleased to announce …